VERA
Vera Therapeutics, Inc.
Key Financials
Operating Income
$-315473000
↓ 88.7%
Net Income
$-299615000
↓ 96.9%
Total Liabilities
$130.2M
↑ 65.8%
Total Assets
$734.7M
↑ 12.1%
Shareholders' Equity
$604.5M
↑ 4.7%
Cash & Equivalents
$354.7M
↑ 282.9%
EPS (Diluted)
$-4.66
↓ 69.5%
Long-term Debt
$74.8M
↑ 47.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 144 | 5/12/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 4 | 4/15/2026 | View on SEC |
| 144 | 4/14/2026 | View on SEC |
| ARS | 4/9/2026 | View on SEC |
| DEFA14A | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VERA |
| Company Name | Vera Therapeutics, Inc. |
| CIK | 1831828 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-770-0077 |